The Avita Medical (ASX:AVH) share price just leapt 16% because of this

The company's CEO commented today's news could spell the future of Avita's technology.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today was a great day on the ASX for the Avita Medical Inc (ASX: AVH) share price.

The medical technology company's stock was boosted by news that the US authority Centers for Medicare and Medicaid Services has approved Avita's application for a new device category code.

The new code means the cost of Avita's RECELL System will be able to be offset when it's used in hospitals and surgical centres.

Avita's RECELL System is a skin restorative system that allows healthcare professionals to restore skin cells to burned areas.

As of Thursday's close, the Avita share price is $15.13, 15.8% higher than it was at Wednesday's close.

Let's take a closer look at today's news from Avita.

Lab worker puts hands in the air and dances around.

Image source: Getty Images

The latest news of the RECELL System

The Avita share price surged higher today as the company's CEO noted the new code could see its RECELL System adopted widely.

According to the company's release, the code under which the RECELL System will soon lie is designed to help facilities adopt new technology by offsetting the cost. The system will adopt the new code on 1 January 2022.

Avita's CEO Mike Perry commented on the news that drove the company's share price, saying:

The new code will enable health care providers to treat burn patients with RECELL in various care settings especially during the pandemic, and over the long run, help foster adoption of RECELL in small burns as well as in future indications.

Perry noted the new code "lays the reimbursement foundation for the soft tissue repair indication". He also said the space represents a $450 million serviceable market.

Previous studies have found that the RECELL System resulted in 97.5% less donor skin being needed to treat second degree burns. Other findings from the studies have also highlighted that the RECELL System means there is 32% less donor skin required to treat patients with third degree burns.

Avita share price snapshot

Today's gain has boosted the Avita share price back into the ASX green.

It is now 1.3% higher than it was at the start of 2021. However, it's still 14.9% lower than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Avita Medical Limited. The Motley Fool Australia has recommended Avita Medical Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A woman holds her hands to her face in shock and fear with a worried expression on her face.
Healthcare Shares

Where to from here for CSL shares according to Macquarie

Is there more pain in store for CSL shareholders?

Read more »

Happy healthcare workers in a lab.
Healthcare Shares

With potential upside of more than 300%, is this ASX biotech the best buy on the ASX right now?

Investors should pay attention to this compelling company.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Healthcare Shares

Is the worst over for CSL shares after this week's sell-off?

It may be too early to completely write off the biotech stock.

Read more »

Senior woman using cpap machine to stop choking and snoring from obstructive sleep apnoea with bokeh and morning light background.
Healthcare Shares

Why are Resmed shares lagging if the business keeps compounding?

Resmed shares have had a tough time of late. But investors looking to compound returns over the long-term may want…

Read more »

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

Why is this ASX 300 share crashing over 20% today?

It is a very red day for this healthcare stock. What's happening? Let's find out.

Read more »

Six smiling health workers pose for a selfie.
Broker Notes

3 reasons this beaten down ASX All Ords healthcare share could come roaring back

A leading analyst believes this beaten down ASX healthcare stock is well-positioned for a comeback.

Read more »

A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.
Healthcare Shares

Down 59%: Will CSL shares ever regain momentum?

Here's what to expect over the next 12 months.

Read more »

A woman sits in front of a computer and does some calculations.
Healthcare Shares

Should you buy ResMed shares at their 52-week low?

This company is still growing, profitable, and exposed to a large sleep health market, but the share price has fallen…

Read more »